Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance

Por Walther, Zenta, Jain, Dhanpat
Publicado em 2011

CASK Deletion in Intestinal Epithelia Causes Mislocalization of LIN7C and the DLG1/Scrib Polarity Complex without Affecting Cell Polarity

Por Lozovatsky, Larissa, Abayasekara, Nirmalee, Piawah, Sorbarikor, Walther, Zenta
Publicado em 2009

A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease

Por Stahl, John M, Walther, Zenta, Chang, Bryan W, Hochster, Howard S, Johung, Kimberly L
Publicado no Cureus (2017)

The Unique-5 and -6 Motifs of ZO-1 Regulate Tight Junction Strand Localization and Scaffolding Properties

Por Fanning, Alan S., Little, Brent P., Rahner, Christoph, Utepbergenov, Darkhan, Walther, Zenta, Anderson, James M.
Publicado em 2007

Human CASK/LIN-2 Binds Syndecan-2 and Protein 4.1 and Localizes to the Basolateral Membrane of Epithelial Cells

Por Cohen, Alexandra R., Wood, Daniel F., Marfatia, Shirin M., Walther, Zenta, Chishti, Athar H., Anderson, James Melvin
Publicado em 1998

A PDZ-Binding Motif Controls Basolateral Targeting of Syndecan-1 Along the Biosynthetic Pathway in Polarized Epithelial Cells

Por Maday, Sandra, Anderson, Eric, Chang, Henry C., Shorter, James, Satoh, Ayano, Sfakianos, Jeff, Fölsch, Heike, Anderson, James M., Walther, Zenta, Mellman, Ira
Publicado em 2008

Mitochondrial Genome Instability and ROS Enhance Intestinal Tumorigenesis in APC(Min/+) Mice

Por Woo, Dong Kyun, Green, Paula D., Santos, Janine H., D'Souza, Anthony D., Walther, Zenta, Martin, W. David, Christian, Brooke E., Chandel, Navdeep S., Shadel, Gerald S.
Publicado em 2012

MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10 deficient mice

Por Hoshi, Namiko, Schenten, Dominik, Nish, Simone A., Walther, Zenta, Gagliani, Nicola, Flavell, Richard A., Reizis, Boris, Shen, Zeli, Fox, James G., Iwasaki, Akiko, Medzhitov, Ruslan
Publicado em 2012

Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1

Por Pirazzoli, Valentina, Nebhan, Caroline, Song, Xiaoling, Wurtz, Anna, Walther, Zenta, Cai, Guoping, Zhao, Zhongming, Jia, Peilin, de Stanchina, Elisa, Shapiro, Erik M., Gale, Molly, Yin, Ruonan, Horn, Leora, Carbone, David P., Stephens, Philip J, Miller, Vincent, Gettinger, Scott, Pao, William, Politi, Katerina
Publicado em 2014

Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer

Por de Bruin, Elza C., Cowell, Catherine, Warne, Patricia H., Jiang, Ming, Saunders, Rebecca E., Melnick, Mary Ann, Gettinger, Scott, Walther, Zenta, Wurtz, Anna, Heynen, Guus J., Heideman, Daniëlle A.M., Gómez-Román, Javier, García-Castaño, Almudena, Gong, Yixuan, Ladanyi, Marc, Varmus, Harold, Bernards, René, Smit, Egbert F., Politi, Katerina, Downward, Julian
Publicado em 2014

Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial

Por Lih, Chih-Jian, Harrington, Robin D., Sims, David J., Harper, Kneshay N., Bouk, Courtney H., Datta, Vivekananda, Yau, Jonathan, Singh, Rajesh R., Routbort, Mark J., Luthra, Rajyalakshmi, Patel, Keyur P., Mantha, Geeta S., Krishnamurthy, Savitri, Ronski, Karyn, Walther, Zenta, Finberg, Karin E., Canosa, Sandra, Robinson, Hayley, Raymond, Amelia, Le, Long P., McShane, Lisa M., Polley, Eric C., Conley, Barbara A., Doroshow, James H., Iafrate, A. John, Sklar, Jeffrey L., Hamilton, Stanley R., Williams, P. Mickey
Publicado no J Mol Diagn (2017)